Atlas Trials

Phase Ⅱ Dose Response Study of NPO-13 in Patients Undergoing Total Colonoscopy

Clinical trial NCT02265939 · COMPLETED

Trial details

NCT number
NCT02265939
Sponsor
Nihon Pharmaceutical Co., Ltd
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Bowel Disease
Start date
2014-10-01
Primary completion
2015-03-01
Enrollment
132

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.